Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.775
-0.075 (-4.05%)
Aug 28, 2026, 12:52 PM EDT - Market open
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $77.47 million as of August 28, 2026. Its market cap has increased by 15.86% in one year.
Market Cap
77.47M
Enterprise Value
64.99M
1-Year Change
15.86%
Ranking
Category
Stock Price
$1.78
ChartMarket Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $77.47M, a decrease of -37.85%. That is a compound annual growth rate of -8.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 77.47M | -37.45% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 84.35M |
| OKYO Pharma | 81.34M |
| Telomir Pharmaceuticals | 80.47M |
| Cingulate | 78.53M |
| Elicio Therapeutics | 78.32M |
| Alterity Therapeutics | 77.80M |
| Cardiff Oncology | 76.56M |
| OS Therapies | 76.11M |